person

Michal Simicek is the scientific director of the Blood Cancer Research Group. He is interested in biochemical, molecular and cellular aspects of haematologic malignancies with a particular focus on the CAR T-cell based immunotherapy. His expertise covers the fields of protein biochemistry, structural, molecular and cell biology. Michal´s team is devoted to resolve fundamental biological